![4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxylic acid](https://static.cymitquimica.com/products/3D/img/FC59377.png "Haga clic para ampliar")
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxylic acid
CAS: 1012058-78-4
Ref. 3D-FC59377
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxylic acid
Descripción:
Regorafenib is a multikinase inhibitor that belongs to the group of targeted therapies. It has been shown to be effective in the treatment of advanced hepatocellular carcinoma and pancreatic cancer. Regorafenib inhibits all three cytochrome P450s (CYP1A2, CYP2C8, and CYP3A4) and can also inhibit other drug metabolizing enzymes such as UGT1A1. Regorafenib is not active against bacteria or fungi, but it has been shown to have anti-inflammatory properties in vitro.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
451.78 g/mol
Fórmula:
C20H13N3O4F3Cl
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
